A detailed history of Gamma Investing LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 390 shares of AMPH stock, worth $18,755. This represents 0.0% of its overall portfolio holdings.

Number of Shares
390
Previous 285 36.84%
Holding current value
$18,755
Previous $12.5 Million 24.66%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

BUY
$38.65 - $43.48 $4,058 - $4,565
105 Added 36.84%
390 $15.6 Million
Q1 2024

Apr 05, 2024

BUY
$42.85 - $63.45 $1,842 - $2,728
43 Added 17.77%
285 $12.5 Million
Q4 2023

Feb 01, 2024

BUY
$44.49 - $62.93 $10,766 - $15,229
242 New
242 $12.9 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.36B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.